Share on StockTwits

Analysts at ISI Group initiated coverage on shares of Allergan (NYSE:AGN) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Analysts at Leerink Swann upgraded shares of Allergan from a “market perform” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $184.00 price target on the stock. Separately, analysts at Zacks reiterated an “outperform” rating on shares of Allergan in a research note on Tuesday, July 22nd. They now have a $205.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Allergan in a research note on Tuesday, July 22nd. They now have a $200.00 price target on the stock, up previously from $190.00. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $161.83.

Shares of Allergan (NYSE:AGN) traded down 0.44% during mid-day trading on Thursday, hitting $165.53. 1,084,385 shares of the company’s stock traded hands. Allergan has a one year low of $86.95 and a one year high of $174.49. The stock has a 50-day moving average of $163.4 and a 200-day moving average of $152.2. The company has a market cap of $49.193 billion and a P/E ratio of 39.11.

Allergan (NYSE:AGN) last issued its quarterly earnings data on Monday, July 21st. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.44 by $0.07. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue for the quarter was up 16.7% on a year-over-year basis. On average, analysts predict that Allergan will post $5.80 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, September 5th. Stockholders of record on Friday, August 15th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.12%. The ex-dividend date of this dividend is Wednesday, August 13th.

Allergan, Inc is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.